149 related articles for article (PubMed ID: 12941938)
1. Oltipraz inhibits 3-methylcholanthrene induction of CYP1A1 by CCAAT/enhancer-binding protein activation.
Cho IJ; Kim SG
J Biol Chem; 2003 Nov; 278(45):44103-12. PubMed ID: 12941938
[TBL] [Abstract][Full Text] [Related]
2. Essential role of phosphatidylinositol 3-kinase-dependent CCAAT/enhancer binding protein beta activation in the induction of glutathione S-transferase by oltipraz.
Kang KW; Cho IJ; Lee CH; Kim SG
J Natl Cancer Inst; 2003 Jan; 95(1):53-66. PubMed ID: 12509401
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional induction of CYP1A1 by oltipraz in human Caco-2 cells is aryl hydrocarbon receptor- and calcium-dependent.
Le Ferrec E; Lagadic-Gossmann D; Rauch C; Bardiau C; Maheo K; Massiere F; Le Vee M; Guillouzo A; Morel F
J Biol Chem; 2002 Jul; 277(27):24780-7. PubMed ID: 11959854
[TBL] [Abstract][Full Text] [Related]
4. CCAAT/enhancer binding protein activation by PD98059 contributes to the inhibition of AhR-mediated 3-methylcholanthrene induction of CYP1A1.
Shin SM; Cho IJ; Kim SG
Xenobiotica; 2005; 35(10-11):975-87. PubMed ID: 16393856
[TBL] [Abstract][Full Text] [Related]
5. CCAAT/ enhancer-binding protein β activation by capsaicin contributes to the regulation of CYP1A1 expression, mediated by the aryl hydrocarbon receptor.
Han EH; Hwang YP; Kim HG; Choi JH; Park BH; Song GY; Lee GW; Jeong TC; Jeong HG
Br J Pharmacol; 2011 Nov; 164(6):1600-13. PubMed ID: 21250977
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of the oxidized metabolites of oltipraz on the activation of CCAAT/enhancer binding protein-beta and NF-E2-related factor-2 for GSTA2 gene induction.
Ko MS; Lee SJ; Kim JW; Lim JW; Kim SG
Drug Metab Dispos; 2006 Aug; 34(8):1353-60. PubMed ID: 16714377
[TBL] [Abstract][Full Text] [Related]
7. Aryl hydrocarbon receptor and NF-E2-related factor 2 are key regulators of human MRP4 expression.
Xu S; Weerachayaphorn J; Cai SY; Soroka CJ; Boyer JL
Am J Physiol Gastrointest Liver Physiol; 2010 Jul; 299(1):G126-35. PubMed ID: 20395535
[TBL] [Abstract][Full Text] [Related]
8. Role of p90 ribosomal S6-kinase-1 in oltipraz-induced specific phosphorylation of CCAAT/enhancer binding protein-beta for GSTA2 gene transactivation.
Lee SJ; Kim SG
Mol Pharmacol; 2006 Jan; 69(1):385-96. PubMed ID: 16246908
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of rat UDP-glucuronosyltransferase 1A6 induction by oltipraz: evidence for a contribution of the Aryl hydrocarbon receptor pathway.
Auyeung DJ; Kessler FK; Ritter JK
Mol Pharmacol; 2003 Jan; 63(1):119-27. PubMed ID: 12488544
[TBL] [Abstract][Full Text] [Related]
10. The induction of CYP1A1 by oltipraz is mediated through calcium-dependent-calpain.
Dale Y; Eltom SE
Toxicol Lett; 2006 Oct; 166(2):150-9. PubMed ID: 16891067
[TBL] [Abstract][Full Text] [Related]
11. Upstream stimulatory factor 1 (USF1) suppresses induction of CYP1A1 mRNA by 3-methylcholanthrene (MC) in HepG2 cells.
Takahashi Y; Nakayama K; Itoh S; Kamataki T
Biochem Biophys Res Commun; 1997 Nov; 240(2):293-7. PubMed ID: 9388470
[TBL] [Abstract][Full Text] [Related]
12. Oltipraz is a bifunctional inducer activating both phase I and phase II drug-metabolizing enzymes via the xenobiotic responsive element.
Miao W; Hu L; Kandouz M; Batist G
Mol Pharmacol; 2003 Aug; 64(2):346-54. PubMed ID: 12869639
[TBL] [Abstract][Full Text] [Related]
13. Single Nucleotide Polymorphisms (SNPs) Distant from Xenobiotic Response Elements Can Modulate Aryl Hydrocarbon Receptor Function: SNP-Dependent CYP1A1 Induction.
Liu D; Qin S; Ray B; Kalari KR; Wang L; Weinshilboum RM
Drug Metab Dispos; 2018 Sep; 46(9):1372-1381. PubMed ID: 29980579
[No Abstract] [Full Text] [Related]
14. Transcriptional activation of the UDP-glucuronosyltransferase 1A7 gene in rat liver by aryl hydrocarbon receptor ligands and oltipraz.
Metz RP; Ritter JK
J Biol Chem; 1998 Mar; 273(10):5607-14. PubMed ID: 9488689
[TBL] [Abstract][Full Text] [Related]
15. Silencing of CYP1A1 expression in rabbits by DNA methylation.
Takahashi Y; Suzuki C; Kamataki T
Biochem Biophys Res Commun; 1998 Jun; 247(2):383-6. PubMed ID: 9642136
[TBL] [Abstract][Full Text] [Related]
16. Enhanced CCAAT/enhancer-binding protein beta-liver-enriched inhibitory protein production by Oltipraz, which accompanies CUG repeat-binding protein-1 (CUGBP1) RNA-binding protein activation, leads to inhibition of preadipocyte differentiation.
Bae EJ; Kim SG
Mol Pharmacol; 2005 Sep; 68(3):660-9. PubMed ID: 15961673
[TBL] [Abstract][Full Text] [Related]
17. Role of hepatitis B virus X repression of C/EBPbeta activity in the down-regulation of glutathione S-transferase A2 gene: implications in other phase II detoxifying enzyme expression.
Cho IJ; Ki SH; Brooks C; Kim SG
Xenobiotica; 2009 Feb; 39(2):182-92. PubMed ID: 19255944
[TBL] [Abstract][Full Text] [Related]
18. Dexamethasone accelerates degradation of aryl hydrocarbon receptor (AHR) and suppresses CYP1A1 induction in placental JEG-3 cell line.
Stejskalova L; Rulcova A; Vrzal R; Dvorak Z; Pavek P
Toxicol Lett; 2013 Nov; 223(2):183-91. PubMed ID: 24091107
[TBL] [Abstract][Full Text] [Related]
19. Induction of 26S proteasome subunit PSMB5 by the bifunctional inducer 3-methylcholanthrene through the Nrf2-ARE, but not the AhR/Arnt-XRE, pathway.
Kwak MK; Kensler TW
Biochem Biophys Res Commun; 2006 Jul; 345(4):1350-7. PubMed ID: 16723119
[TBL] [Abstract][Full Text] [Related]
20. NF-kappaB activation by the chemopreventive dithiolethione oltipraz is exerted through stimulation of MEKK3 signaling.
Nho CW; O'Dwyer PJ
J Biol Chem; 2004 Jun; 279(25):26019-27. PubMed ID: 15047705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
